Basic Information
Basic information for SNHG17-243-14aa
Peptide Name SNHG17-243-14aa
Genome Position chr20:38422091-38422132[-]
Species Human
Peptide Sequence MCCSWGLDDVGEAR
Peptide Length 14
Unique No (SNHG17-201-14aa,SNHG17-202-14aa-2,SNHG17-206-14aa,SNHG17-209-14aa,SNHG17-210-14aa,SNHG17-211-14aa,SNHG17-213-14aa,SNHG17-214-14aa,SNHG17-215-14aa,SNHG17-216-14aa,SNHG17-218-14aa,SNHG17-219-14aa,SNHG17-223-14aa-2,SNHG17-224-14aa-1,SNHG17-225-14aa,SNHG17-228-14aa,SNHG17-229-14aa,SNHG17-230-14aa-1,SNHG17-231-14aa-2,SNHG17-233-14aa-2,SNHG17-235-14aa,SNHG17-236-14aa,SNHG17-238-14aa,SNHG17-239-14aa,SNHG17-240-14aa,SNHG17-241-14aa,SNHG17-242-14aa,SNHG17-244-14aa,SNHG17-246-14aa,SNHG17-247-14aa,SNHG17-249-14aa,SNHG17-252-14aa,SNHG17-254-14aa,SNHG17-255-14aa,SNHG17-257-14aa,SNHG17-258-14aa-1,SNHG17-259-14aa,SNHG17-260-14aa,SNHG17-261-14aa,SNHG17-262-14aa,SNHG17-263-14aa,SNHG17-264-14aa,SNHG17-266-14aa,SNHG17-267-14aa-2,SNHG17-268-14aa,SNHG17-269-14aa,SNHG17-270-14aa,SNHG17-272-14aa-1,SNHG17-273-14aa,SNHG17-274-14aa-1,SNHG17-275-14aa,SNHG17-276-14aa,SNHG17-277-14aa,SNHG17-278-14aa-2,SNHG17-279-14aa,SNHG17-280-14aa-2,SNHG17-281-14aa,SNHG17-282-14aa,SNHG17-283-14aa,SNHG17-284-14aa-2,SNHG17-285-14aa,SNHG17-286-14aa,SNHG17-287-14aa,SNHG17-288-14aa,SNHG17-289-14aa)
Grand Average of Hydropathicity -0.0571
Relative Molecular Mass 1775.92
Experimental Evidences 2:m6A,ribo
lncRNA ID/Name ENSG00000196756;SNHG17
Transcript ID/Name ENST00000660064;SNHG17-243
Transcript Length 1444
Coding Ability 0.5976
DNA Sequence Corresponding to Peptide ATGTGCTGTTCCTGGGGCTTGGATGATGTAGGGGAAGCAAGG
Experimental Evidences
   m6A
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :